J. Jones

发表

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

H. Klocker, M. Kattan, E. Steyerberg, 2011, World Journal of Urology.

Operative urology at the Cleveland Clinic

J. Jones, A. Novick, I. Gill, 2006 .

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel

Hessel Wijkstra, John Kurhanewicz, Osamu Ukimura, 2014, BJU international.

Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors.

Thomas Anil, Li Jianbo, K. Fareed, 2011, Urology.

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Andrew J. Vickers, Jenny Donovan, Helmut Klocker, 2010, Clinical Cancer Research.

1to Carcinoma In Situ (CIS)

J. Jones, J. Jones, 2010 .

Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: Initial results from the cryo on‐line data registry

J. Jones, Yong-hong Li, A. ElShafei, 2015, The Prostate.

Saturation prostate biopsy with periprostatic block can be performed in office.

J. Jones, C. Zippe, M. Oder, 2002, The Journal of urology.

Value of Serial PSA Measurements for Prostate Cancer Prediction on Screening Using a Maximum Likelihood Estimation − Prostate Specific Antigen (MLE-PSA) Model

K. Fareed, J. Jones, R. Berglund, 2012, Journal of Data Science.

Prostate cancer volume at biopsy predicts clinically significant upgrading.

C. Magi-Galluzzi, E. Klein, J. Jones, 2008, The Journal of urology.

A nomogram for predicting upgrading in patients with low‐ and intermediate‐grade prostate cancer in the era of extended prostate sampling

M. Kattan, K. Fareed, J. Jones, 2010, BJU international.

Can residents perform transrectal ultrasound-guided prostate biopsy with patient comfort comparable to biopsy performed by attending staff urologists?

J. Jones, C. Nguyen, T. Gao, 2010, Prostate Cancer and Prostatic Diseases.

The prostate needle biopsy gun: busting a myth.

J. Jones, J Stephen Jones, Amit R Patel, 2007, The Journal of urology.

Male genital morphology and function: an evolutionary perspective.

J. Jones, M. Simmons, J. Jones, 2007, The Journal of urology.

Parasagittal biopsies add minimal information in repeat saturation prostate biopsy.

J. Jones, C. Zippe, J. Rabets, 2004, Urology.

The role of pathology review of transurethral bladder tumor resection specimens in the modern era.

H. Levin, J. Jones, M. C. Lee, 2010, The Journal of urology.

Defining the role of NMP22 in bladder cancer surveillance

J. Jones, C. Nguyen, J. Jones, 2008, World Journal of Urology.

Focal cryotherapy for localized prostate cancer: A report from the national Cryo On-Line Database (COLD) Registry

J. Jones, J. Ward, J. Jones, 2012 .

Determining the success of vasectomy

Amit Bhatt, J. Jones, J Stephen Jones, 2006, BJU international.

A prospective evaluation of the impact of scheduled follow‐up appointments with compliance rates after vasectomy

J. Jones, A. Bhatt, N. Dhar, 2007, BJU international.

Percutaneous vasectomy: a simple modification eliminates the steep learning curve of no-scalpel vasectomy.

J. Jones, J. Jones, 2003, The Journal of urology.

Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma.

J. Jones, D. Hansel, A. Smith, 2008, Urology.

Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening

J. Jones, U. Lee, J. Jones, 2009, Prostate Cancer and Prostatic Diseases.

Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management.

J. Jones, B. Lane, S. Campbell, 2011, Urology.

More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.

K. Fareed, E. Klein, J. Jones, 2016, The Journal of urology.

Diagnostically challenging cases: what are atypia and dysplasia?

J. Jones, D. Hansel, Joseph M Sanfrancesco, 2013, The Urologic clinics of North America.

Bupivacaine provides rapid, effective periprostatic anaesthesia for transrectal prostate biopsy

J. Jones, C. Zippe, J. Rabets, 2004, BJU international.

Prostate Cancer Detection: Lessons Learned in the Cleveland Clinic Experience with Focus on the Negative Biopsy

J. Jones, Ayman S Moussa, Osama M. Zaytoun, 2013 .

Disease burden predicts for favorable post salvage cryoablation PSA.

J. Jones, Jianbo Li, D. Levy, 2010, Urology.

Open to debate. The motion: at least 18 cores are necessary to make a prostatic biopsy useful.

E. Klein, J. Jones, A. De la taille, 2008, European urology.

Optimal Prostate Biopsy Regimen

J. Jones, R. Berglund, J. Jones, 2012, Current Urology Reports.

Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer

E. Klein, J. Jones, Ayman S Moussa, 2009, BJU international.

Statin use and risk of prostate cancer in a population of men who underwent biopsy.

E. Klein, J. Jones, N. Tan, 2011, The Journal of urology.

Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.

K. Fareed, J. Jones, C. Zippe, 2014, Urology.

Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria.

E. Klein, J. Jones, A. Stephenson, 2011, Urology.

Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.

J. Jones, B. Lane, N. Tan, 2008, The Journal of urology.

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care

Grant L. Hom, M. Kattan, E. Klein, 2018, Front. Oncol..

The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation.

J. Jones, S. Armstrong, M. Gavaghan, 2013, The Canadian journal of urology.

Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?

J. McKenney, C. Magi-Galluzzi, E. Klein, 2015, BJU international.

Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy

C. Magi-Galluzzi, E. Klein, J. Jones, 2012, The Prostate.

Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.

J. Jones, S. Campbell, D. Hansel, 2009, Human pathology.

Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA era

J. Jones, H. Follis, J. R. Johnson, 2009, Prostate Cancer and Prostatic Diseases.

Editorial Comment.

J. Jones, 2020, The Journal of urology.

Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population

E. Klein, J. Jones, C. Weight, 2008, Cancer.

Identification of the variables associated with pain during transrectal ultrasonography‐guided prostate biopsy in the era of periprostatic nerve block: the role of transrectal probe configuration

K. Fareed, J. Jones, E. Diaz, 2013, BJU international.

Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer

E. Klein, J. Jones, R. Berglund, 2012, BJU international.

Tissue-Preserving Surgical Approaches in Urologic Oncology: The Therapeutic Mechanism for Tumor Ablation

J. Jones, Ganesh K Kartha, J. Jones, 2017 .

Category IV Prostatitis: Implications for Prostate Cancer Screening, Diagnosis, and Carcinogenesis

J. Jones, J. Jones, 2008 .

Lidocaine 2% gel versus plain lubricating gel for pain reduction during flexible cystoscopy: a meta-analysis of prospective, randomized, controlled trials.

J. Jones, D. Babineau, Amit R. Patel, 2008, The Journal of urology.

Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance.

C. Magi-Galluzzi, E. Klein, J. Jones, 2019, Urology.

For Single Dosing, Levofloxacin Is Superior to Ciprofloxacin When Combined With an Aminoglycoside in Preventing Severe Infections After Prostate Biopsy.

E. Klein, J. Jones, H. Goldman, 2015, Urology.

Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.

J. Kaouk, E. Klein, J. Jones, 2006, Urology.

Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry.

J. Jones, A. Ross, V. Mouraviev, 2016, Journal of endourology.

Safe initiation of a laparoendoscopic single site living donor nephrectomy program in a small-volume transplant center.

Alice M. Jones, J. Jones, S. Chueh, 2013, Urology.

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project

T. D. de Reijke, S. Crouzet, A. Villers, 2016, World Journal of Urology.

Management of ureteral injuries associated with vaginal surgery for pelvic organ prolapse

J. Jones, F. Daneshgari, H. Goldman, 2006, International Urogynecology Journal.

Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.

M. Kattan, J. Jones, Changhong Yu, 2011, Urology.

Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.

J. Jones, C. Zippe, R. Tubbs, 2003, The Journal of urology.

The use of urine-based biomarkers in bladder cancer.

V. Reuter, H. Grossman, M. Blute, 2006, Urology.

Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?

J. Jones, Adrian V. Hernández, Ayman S Moussa, 2013, Urology.

Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intra-epithelial neoplasia.

J. Jones, Changhong Yu, Ayman S Moussa, 2011, Urology.

Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.

M. Kattan, C. Magi-Galluzzi, J. Jones, 2010, The Journal of urology.

Herpes zoster infection of the chest wall and the syndrome of inappropriate antidiuretic hormone secretion.

J. Jones, D. Maclean, T. Sato, 1990, Southern medical journal.

When serial prostate biopsy is recommended: most cancers detected are clinically insignificant

K. Fareed, J. Jones, A. Stephenson, 2012, BJU international.

Primary full‐gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry

J. Jones, M. Cher, J. Ward, 2011, BJU international.

Primary cryoablation nadir prostate specific antigen and biochemical failure.

J. Jones, L. Pisters, D. Levy, 2009, The Journal of urology.

Efficacy and tolerability of fesoterodine in men with overactive bladder: a pooled analysis of 2 phase III studies.

J. Jones, M. Oelke, S. Herschorn, 2010, Urology.

Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder

E. Klein, J. Jones, S. Campbell, 2008, BJU international.

Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation

J. Jones, Changhong Yu, K. Ginsburg, 2017, The Prostate.

Implications of cancer on male fertility

J. Jones, A. Ragheb, E. Sabanegh, 2009 .

DNA-based molecular cytology for bladder cancer surveillance.

J. Jones, J. Jones, 2006, Urology.

Editorial Comment.

J. Jones, J. Jones, 2019, The Journal of urology.

UROLOGISTS: BE AWARE OF SIGNIFICANT RISKS TO STOPPING ANTICOAGULANTS IN PATIENTS WITH DRUG‐ELUTING CORONARY STENTS

J. Jones, J. Jones, 2007, BJU international.

Focal or Subtotal Therapy for Early Stage Prostate Cancer

J. Jones, J. Jones, 2007, Current treatment options in oncology.

Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer.

J. Jones, C. Nguyen, J. Ulchaker, 2009, Urology.

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high‐risk cohort of men with negative initial prostate biopsies

B. Trock, A. Partin, J. Epstein, 2012, BJU international.

Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population.

K. Fareed, J. Jones, T. Gao, 2011, The Journal of urology.

The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy

J. Jones, Ayman S Moussa, Jianbo Li, 2013, The Prostate.

Re: Anup Patel. Re: Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. Eur Urol. 2012;61:223-4.

J. Jones, 2012, European urology.

Rectal sensation test helps avoid pain of apical prostate biopsy.

J. Jones, C. Zippe, 2003, The Journal of urology.

Classification system: organ preserving treatment for prostate cancer.

J. Jones, J. Ward, J. Jones, 2010, Urology.

Definition of biochemical success following primary whole gland prostate cryoablation.

J. Jones, A. Ross, A. ElShafei, 2014, The Journal of urology.

Adult Scrotal Surgery

J. Jones, G. Deoreo, 2006 .

Determining Focal Therapy Failure and Salvage Options

J. Jones, T. Reijke, A. Postema, 2017 .

Does Any Racial Disparity Exist in Oncologic Outcomes After Primary Cryotherapy for Prostate Cancer? A Matched‐pair Comparative Analysis of the Cryo On‐Line Data Registry

J. Jones, T. Polascik, M. Tsivian, 2018, Clinical genitourinary cancer.